Manuel Heurich

Dr. Manuel Heurich


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Viruses
Verified
Journal Article
Open access
PDF file
EBEva Bernauer
Eva Bernauer
FAFelix Alebrand
Felix Alebrand
MHManuel Heurich
Manuel Heurich
Background: Acute respiratory distress syndrome (ARDS) is a severe lung condition that can be caused by a variety of underlying illnesses. Due to SARS-CoV-2, the number of cases with ARDS has increased worldwide, making it essential to compare this form of acute respiratory failure with classical causes of ARDS. While there have been several studies investigating the differences between COVID-19 and non-COVID-19 ARDS in early stages of the pandemic, little is known about the differences in later phases, especially in Germany. Aim: The aim of this study is to characterize and compare the comorbidities, treatments, adverse events, and outcomes of COVID-19-associated ARDS and non-COVID-19 ARDS using a representative sample of German health claims data from the years 2019 and 2021. Methods: We compare percentages and median values of the quantities of interest from the COVID-19 and non-COVID-19 ARDS group, with p-values calculated after conducting Pearson’s chi-squared test or the Wilcoxon rank sum test. We also run logistic regressions to access the effect of comorbidities on mortality for COVID-19 ARDS and non-COVID-19 ARDS. Results: Despite many similarities, we find that that there are some remarkable differences between COVID-19 and non-COVID-19 ARDS cases in Germany. Most importantly, COVID-19 ARDS cases display fewer comorbidities and adverse events, and are more often treated with non-invasive ventilation and nasal high-flow therapy. Conclusions: This study highlights the importance of comprehending the contrasting epidemiological features and clinical outcomes of COVID-19 and non-COVID-19 ARDS. This understanding can aid in clinical decision making and guide future research initiatives aimed at enhancing the management of patients afflicted with this severe condition.


1 January 2024
Verified
Report
Closed access
MHManuel Heurich
Manuel Heurich
ADAnne Demond
Anne Demond
Als Real World Evidence (RWE) bezeichnet man die gewonnenen medizinischen Erkenntnisse, die aus Beobachtungsstudien und der Darstellung der Versorgungsrealität mit Massendatenquellen (Big Data) gewonnen werden (Behrendt 2019). Sie erlauben im Gegensatz zu randomisierten klinischen Studien häufig eine höhere Generalisierbarkeit (externe Validität) (Ziemssen et al. 2017). Die interne Validität hingegen ist bei der Real World Evidence im Vergleich zu klassischen randomisierten klinischen Studien (interventionelle Studien) als geringer anzusehen, da im Vorfeld der Studien bzw. Beobachtungen keine geplanten Eingriffe (Interventionen) erfolgen, um mögliche Verzerrungen auszuschließen (Vogelmann 2019).

18 April 2018
Verified
Book Chapter
Closed access
PDF file
MHManuel Heurich
Manuel Heurich
MHMarkus Heider
Markus Heider
SSSven Seemann
Sven Seemann